S&P 500   3,967.76 (+0.48%)
DOW   32,214.92 (+0.34%)
QQQ   310.55 (+0.26%)
AAPL   159.97 (+0.65%)
MSFT   279.93 (+0.82%)
META   206.05 (+0.87%)
GOOGL   105.33 (-0.26%)
AMZN   97.93 (-0.79%)
TSLA   189.85 (-1.23%)
NVDA   267.32 (-1.69%)
NIO   9.06 (-2.27%)
BABA   86.70 (+0.21%)
AMD   97.87 (-2.40%)
T   18.61 (+0.81%)
F   11.49 (+0.61%)
MU   60.96 (-0.62%)
CGC   1.91 (-0.26%)
GE   91.07 (-0.57%)
DIS   94.01 (-1.90%)
AMC   4.43 (-0.89%)
PFE   40.31 (+0.32%)
PYPL   73.68 (+1.54%)
NFLX   328.22 (+2.45%)
S&P 500   3,967.76 (+0.48%)
DOW   32,214.92 (+0.34%)
QQQ   310.55 (+0.26%)
AAPL   159.97 (+0.65%)
MSFT   279.93 (+0.82%)
META   206.05 (+0.87%)
GOOGL   105.33 (-0.26%)
AMZN   97.93 (-0.79%)
TSLA   189.85 (-1.23%)
NVDA   267.32 (-1.69%)
NIO   9.06 (-2.27%)
BABA   86.70 (+0.21%)
AMD   97.87 (-2.40%)
T   18.61 (+0.81%)
F   11.49 (+0.61%)
MU   60.96 (-0.62%)
CGC   1.91 (-0.26%)
GE   91.07 (-0.57%)
DIS   94.01 (-1.90%)
AMC   4.43 (-0.89%)
PFE   40.31 (+0.32%)
PYPL   73.68 (+1.54%)
NFLX   328.22 (+2.45%)
S&P 500   3,967.76 (+0.48%)
DOW   32,214.92 (+0.34%)
QQQ   310.55 (+0.26%)
AAPL   159.97 (+0.65%)
MSFT   279.93 (+0.82%)
META   206.05 (+0.87%)
GOOGL   105.33 (-0.26%)
AMZN   97.93 (-0.79%)
TSLA   189.85 (-1.23%)
NVDA   267.32 (-1.69%)
NIO   9.06 (-2.27%)
BABA   86.70 (+0.21%)
AMD   97.87 (-2.40%)
T   18.61 (+0.81%)
F   11.49 (+0.61%)
MU   60.96 (-0.62%)
CGC   1.91 (-0.26%)
GE   91.07 (-0.57%)
DIS   94.01 (-1.90%)
AMC   4.43 (-0.89%)
PFE   40.31 (+0.32%)
PYPL   73.68 (+1.54%)
NFLX   328.22 (+2.45%)
S&P 500   3,967.76 (+0.48%)
DOW   32,214.92 (+0.34%)
QQQ   310.55 (+0.26%)
AAPL   159.97 (+0.65%)
MSFT   279.93 (+0.82%)
META   206.05 (+0.87%)
GOOGL   105.33 (-0.26%)
AMZN   97.93 (-0.79%)
TSLA   189.85 (-1.23%)
NVDA   267.32 (-1.69%)
NIO   9.06 (-2.27%)
BABA   86.70 (+0.21%)
AMD   97.87 (-2.40%)
T   18.61 (+0.81%)
F   11.49 (+0.61%)
MU   60.96 (-0.62%)
CGC   1.91 (-0.26%)
GE   91.07 (-0.57%)
DIS   94.01 (-1.90%)
AMC   4.43 (-0.89%)
PFE   40.31 (+0.32%)
PYPL   73.68 (+1.54%)
NFLX   328.22 (+2.45%)
NASDAQ:ACER

Acer Therapeutics - ACER News Today

$0.75
-0.02 (-2.85%)
(As of 03/24/2023 03:52 PM ET)
Add
Compare
Today's Range
$0.75
▼
$0.80
50-Day Range
$0.67
▼
$3.00
52-Week Range
$0.65
▼
$4.56
Volume
117,480 shs
Average Volume
468,240 shs
Market Capitalization
$15.80 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Get Acer Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for ACER and its competitors with MarketBeat's FREE daily newsletter.


ACER Media Mentions By Week

ACER Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

ACER
News Sentiment
▼
0.13

0.36
▲
Average
Medical
News Sentiment

ACER News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

ACER Articles
This Week
▼
7

1
▲
ACER Articles
Average Week

SourceHeadline
finanznachrichten.de logoAcer Therapeutics Inc.: Acer Therapeutics Announces $2.675 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
finanznachrichten.de - March 22 at 3:35 PM
tmcnet.com logoAcer Therapeutics Announces Data Presented at Society for Inherited Metabolic Disorders Annual Meeting Identifying Preferred Urea Cycle Disorder
tmcnet.com - March 22 at 3:35 PM
finance.yahoo.com logoAcer Therapeutics Announces $2.675 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
finance.yahoo.com - March 22 at 10:35 AM
finance.yahoo.com logoAcer Therapeutics Announces Data Presented at Society for Inherited Metabolic Disorders Annual Meeting Identifying Preferred Urea Cycle Disorder Treatment Attributes
finance.yahoo.com - March 22 at 10:35 AM
reuters.com logoTwo new vaccines against bird flu effective in Dutch lab -govt
reuters.com - March 17 at 11:47 PM
reuters.com logoUK healthcare workers to decide on new pay offer by end of April -unions
reuters.com - March 17 at 11:47 PM
finanznachrichten.de logoAcer Therapeutics Inc.: Acer Therapeutics Announces Topline Results from ACER-801 (Osanetant) Phase 2a Trial
finanznachrichten.de - March 17 at 1:47 PM
seekingalpha.com logoAcer stock slumps ~45% as ACER-801 paused after hot flashes trial disappoints; cash woes
seekingalpha.com - March 17 at 1:47 PM
marketwatch.com logoAcer Therapeutics Shares Hit 52-Week Low After ACER-801 Trial Misses Topline Results
marketwatch.com - March 17 at 1:47 PM
reuters.com logoAcer Therapeutics to pause trial of hot flashes drug
reuters.com - March 17 at 1:47 PM
bizjournals.com logoNewton biotech's drug for hot flashes due to menopause fails trial
bizjournals.com - March 17 at 1:47 PM
finance.yahoo.com logoAcer Therapeutics' Product Acquired From Sanofi Fails In Menopause Study
finance.yahoo.com - March 17 at 1:47 PM
finance.yahoo.com logoAcer Therapeutics Announces Topline Results from ACER-801 (Osanetant) Phase 2a Trial
finance.yahoo.com - March 17 at 8:47 AM
finance.yahoo.com logoAcer Therapeutics Announces Presentation of HCP Urea Cycle Disorder Treatment Preference Data at the Society for Inherited Metabolic Disorders Annual Meeting and Provides OLPRUVA™ Program Update
finance.yahoo.com - March 15 at 12:55 PM
uk.finance.yahoo.com logoRelief Therapeutics Provides Update From Collaboration Partner on OLPRUVA™
uk.finance.yahoo.com - March 15 at 7:55 AM
finance.yahoo.com logoRelief Therapeutics Provides Update From Collaboration Partner on OLPRUVA
finance.yahoo.com - March 15 at 7:55 AM
finance.yahoo.com logoACER Feb 2023 2.500 call
finance.yahoo.com - February 18 at 9:06 AM
finance.yahoo.com logoAcer Therapeutics Inc. (ACER) Interactive Stock Chart - Yahoo Finance
finance.yahoo.com - February 14 at 1:32 AM
finance.yahoo.com logoAcer Therapeutics Announces Full Enrollment of Phase 2a Trial of ACER-801 (Osanetant) for Treatment of Moderate to Severe Vasomotor Symptoms Associated with Menopause
finance.yahoo.com - February 13 at 10:31 AM
finance.yahoo.com logoAcer (ACER) to Report Q4 Earnings: What's in the Cards?
finance.yahoo.com - February 10 at 2:26 PM
forbes.com logoAcer Therapeutics
forbes.com - January 27 at 12:39 PM
finance.yahoo.com logoAcer Therapeutics Inc. (ACER) Gains As Market Dips: What You Should Know
finance.yahoo.com - January 25 at 10:55 PM
finance.yahoo.com logoAcer Therapeutics Inc. (ACER) Dips More Than Broader Markets: What You Should Know
finance.yahoo.com - January 19 at 10:20 PM
finance.yahoo.com logoAcer Therapeutics Inc. (ACER) Stock Sinks As Market Gains: What You Should Know
finance.yahoo.com - January 10 at 11:15 PM
benzinga.com logoAcer Therapeutics Highlights Key 2022 Achievements and Pipeline Advancements, and Provides Anticipated 2023 Milestones
benzinga.com - January 9 at 9:50 AM
finance.yahoo.com logoAcer Therapeutics Highlights Key 2022 Achievements and Pipeline Advancements, and Provides Anticipated 2023 Milestones
finance.yahoo.com - January 9 at 9:50 AM
finance.yahoo.com logoAcer Therapeutics Announces Initiation of Two Investigator-Sponsored Trials of ACER-801 (Osanetant) in Men with Adenocarcinoma of the Prostate
finance.yahoo.com - January 5 at 10:16 AM
msn.com logoHow Is The Market Feeling About Acer Therapeutics?
msn.com - January 3 at 3:02 PM
finanznachrichten.de logoAcer Therapeutics Inc.: Acer Therapeutics Compliant with All Nasdaq Listing Criteria
finanznachrichten.de - December 29 at 2:17 PM
msn.com logoAcer Therapeutics regains compliance with Nasdaq listing rule
msn.com - December 29 at 2:17 PM
finance.yahoo.com logoAre Medical Stocks Lagging Acer Therapeutics (ACER) This Year?
finance.yahoo.com - December 29 at 2:17 PM
finance.yahoo.com logoAre Medical Stocks Lagging Acer Therapeutics (ACER) This Year?
finance.yahoo.com - December 29 at 2:17 PM
finance.yahoo.com logoAcer Therapeutics Compliant with All Nasdaq Listing Criteria
finance.yahoo.com - December 29 at 9:17 AM
finance.yahoo.com logoACER Down Despite FDA Nod for Urea Cycle Disorders Drug
finance.yahoo.com - December 28 at 1:32 PM
finance.yahoo.com logoAcer Therapeutics Inc. (ACER) Upgraded to Strong Buy: What Does It Mean for the Stock?
finance.yahoo.com - December 28 at 1:32 PM
markets.businessinsider.com logoAcer Therapeutics Announces U.S. FDA Approval Of OLPRUVA For Urea Cycle Disorders
markets.businessinsider.com - December 27 at 2:39 PM
markets.businessinsider.com logoAcer Therapeutics and Relief Therapeutics Announce U.S. FDA Approval of OLPRUVA for Patients with Urea Cycle Disorders
markets.businessinsider.com - December 27 at 9:39 AM
finance.yahoo.com logoAcer Therapeutics and Relief Therapeutics Announce U.S. FDA Approval of OLPRUVA™ for Patients with Urea Cycle Disorders
finance.yahoo.com - December 27 at 9:39 AM
marketwatch.com logoAcer Therapeutics Gets FDA Approval for Lead Drug Candidate Olpruva
marketwatch.com - December 23 at 7:43 PM
reuters.com logoU.S. FDA approves Acer Therapeutics' genetic disorder drug
reuters.com - December 23 at 7:43 PM
finance.yahoo.com logoUPDATE 1-U.S. FDA approves Acer Therapeutics' genetic disorder drug
finance.yahoo.com - December 23 at 7:43 PM
markets.businessinsider.com logoRelief Therapeutics to Participate in January Investor Meetings
markets.businessinsider.com - December 14 at 2:57 AM
finance.yahoo.com logoIs Acer Therapeutics (ACER) Stock Outpacing Its Medical Peers This Year?
finance.yahoo.com - December 13 at 4:56 PM
finance.yahoo.com logoTrade Alert: The Founder Of Acer Therapeutics Inc. (NASDAQ:ACER), Christopher Schelling, Has Just Spent US$1m Buying 43% More Shares
finance.yahoo.com - December 4 at 2:35 PM
finance.yahoo.com logoAcer Therapeutics Announces $1.5M Private Placement
finance.yahoo.com - November 30 at 10:14 AM
finance.yahoo.com logoAcer Therapeutics Third Quarter 2022 Earnings: US$0.31 loss per share (vs US$0.23 loss in 3Q 2021)
finance.yahoo.com - November 17 at 11:54 AM
finanznachrichten.de logoAcer Therapeutics Inc.: Acer Therapeutics Reports Q3 2022 Financial Results and Provides Corporate Update
finanznachrichten.de - November 15 at 5:31 PM
finance.yahoo.com logoAcer Therapeutics Reports Q3 2022 Financial Results and Provides Corporate Update
finance.yahoo.com - November 15 at 2:25 AM
markets.businessinsider.com logoRelief Therapeutics Holding SA and NRx Pharmaceuticals, Inc. Announce Execution of Definitive Settlement Agreements
markets.businessinsider.com - November 14 at 1:28 AM
finance.yahoo.com logoAcer Therapeutics Receives Notice of Allowance of Key US Patent Application Covering EDSIVO™ (celiprolol)
finance.yahoo.com - October 26 at 11:22 AM
Get Acer Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for ACER and its competitors with MarketBeat's FREE daily newsletter.

This page (NASDAQ:ACER) was last updated on 3/24/2023 by MarketBeat.com Staff